Targeting ANGPTL8 as a novel strategy to alleviate glomerular podocyte injury in diabetic nephropathy

This publication has 44 references indexed in Scilit:

• Associations of ANGPTL proteins and complexes with progression of coronary artery calcification and coronary events
  Atherosclerosis, 2025
• Isolinderalactone suppresses pancreatic ductal adenocarcinoma by activating p38 MAPK to promote DDIT3 expression and trigger endoplasmic reticulum stress
  International Immunopharmacology, 2024
• Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects
  Biomedicine & Pharmacotherapy, 2023
• Angiopoietin-like protein 8 deficiency attenuates thoracic aortic aneurysm/dissection development in β-aminopropionitrile monofumarate-induced model mice
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2022
• A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane
  Journal of Molecular Medicine, 2021
• Angiopoietin-like protein 8 accelerates atherosclerosis in ApoE−/− mice
  Atherosclerosis, 2020
• ER stress response mediates diabetic microvascular complications
  Drug Discovery Today, 2019
• Gpihbp1 deficiency accelerates atherosclerosis and plaque instability in diabetic Ldlr-/- mice
  Atherosclerosis, 2019
• Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents
  Diabetologia, 2018
• Advanced oxidation protein products decrease expression of nephrin and podocin in podocytes via ROS-dependent activation of p38 MAPK
  Science China Life Sciences, 2010